CARDIFF ONCOLOGY INC earnings per share and revenue

XE7C earnings per share for the last quarter are -0.21 EUR whereas the estimation was -0.24 EUR which accounts for 10.70% surprise. Company revenue for the same period amounts to 147.79 k EUR despite the estimated figure of 96.60 k EUR. Estimated earnings per share for the next quarter are -0.19 EUR, and revenue is expected to reach 84.15 k EUR. Also watch annual changes over time to get a bigger picture of XE7C earnings per share and revenue dynamics.